Author:
Villalobos-Molina Rafael,Ibarra Maximiliano,Hong Enrique
Reference19 articles.
1. Some quantitative uses of drug antagonists;Arunlakshana;Br. J. Pharmacol.,1959
2. Pharmacological evidence for interactions between 5-HT1A receptor agonists and subtypes of α1-adrenoceptors on rabbit aorta;Castillo;Eur. J. Pharmacol.,1993
3. Vascular effects of ipsapirone are related with subtypes of α1-adrenergic receptors;Castillo;Arch. Med. Res.,1993
4. Central 5-HT1A receptors and the mechanism of the hypotensive effect of (+)-8-OH-DPAT, DP-5-CT, R28935, and urapidil;Doods;J. Cardiovasc. Pharmacol.,1988
5. The adrenoceptor agonist, SDZ NVI 085, discriminates between α1A- and α1B-adrenoceptor subtypes in vas deferens, kidney and aorta of rat;Eltze;Eur. J. Pharmacol.,1992
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. In Situ Carbonylative Synthesis of Aromatic Esters and Formation of Quinazoline‐2,4(1H,3H)‐diones by Chemical Fixation of CO
2
in Assistance of Polymer‐Supported Palladium Catalyst;ChemistrySelect;2020-09-03
2. Catalytic formation of N3-substituted quinazoline-2,4(1H,3H)-diones by Pd(ii)EN@GO composite and its mechanistic investigations through DFT calculations;New Journal of Chemistry;2020
3. Palladium-Catalyzed Cyclization Reaction of o
-Haloanilines, CO2
and Isocyanides: Access to Quinazoline-2,4(1H
,3H
)-diones;Chinese Journal of Chemistry;2017-12-13
4. Pelanserin: 3-[3-(4-phenylpiperazin-1-yl)propyl]quinazoline-2,4(1H,3H)-dione;Acta Crystallographica Section E Structure Reports Online;2014-07-23
5. Synthesis, Structure of Zwitterionic 2-Amino-N′-(imidazolidin-2-ylidene)benzohydrazides, and Their Transformation into 3-(Imidazolidin-2-ylideneamino)quinazolin-4(1H)-one Derivatives;Journal of Heterocyclic Chemistry;2012-11